These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8797944)

  • 1. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
    Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC
    Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
    Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
    Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
    Kettritz U; Schlund JF; Wilbur K; Eisenberg LB; Semelka RC
    Magn Reson Imaging; 1996; 14(10):1185-90. PubMed ID: 9065909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
    Diehl SJ; Lehmann KJ; Gaa J; McGill S; Hoffmann V; Georgi M
    Invest Radiol; 1999 Sep; 34(9):589-95. PubMed ID: 10485075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced MR cholangiography: comparison of Gd-EOB-DTPA and Mn-DPDP in healthy volunteers.
    Bae K; Na JB; Choi DS; Cho JM; Choi HC; Jeon KN; Park MJ; Choi HY; Kim JE; Chung SH
    Br J Radiol; 2012 Sep; 85(1017):1250-4. PubMed ID: 22553292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic enhancement after low-dose infusion of Mn-DPDP.
    Gehl HB; Vorwerk D; Klose KC; Günther RW
    Radiology; 1991 Aug; 180(2):337-9. PubMed ID: 1906189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
    Gong J; Xu J; Zhou K; Shen K
    Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
    Coffin CM; Diche T; Mahfouz A; Alexandre M; Caseiro-Alves F; Rahmouni A; Vasile N; Mathieu D
    Eur Radiol; 1999; 9(3):444-9. PubMed ID: 10087113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic contrast enhancement with Mn-bis pyridoxal ethylene diamine diacetic acid and the influence of a hormonal stimulation of the pancreas in pigs.
    Blume J; Palmié S; Aue B; Spielmann RP; Sievers E; Lodemann KP; Heller M
    Acad Radiol; 1994 Nov; 1(3):253-60. PubMed ID: 9419495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
    Slater GJ; Saini S; Mayo-smith WW; Sharma P; Eisenberg PJ; Hahn PF
    Clin Radiol; 1996 Jul; 51(7):484-6. PubMed ID: 8689823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization.
    Ni Y; Marchal G; Yu J; Mühler A; Lukito G; Baert AL
    J Magn Reson Imaging; 1994; 4(3):355-63. PubMed ID: 8061434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
    Martin DR; Semelka RC; Chung JJ; Balci NC; Wilber K
    Magn Reson Imaging; 2000 Oct; 18(8):955-63. PubMed ID: 11121698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images.
    Vogl TJ; Hamm B; Schnell B; McMahon C; Branding G; Lissner J; Wolf KJ
    J Magn Reson Imaging; 1993; 3(1):51-8. PubMed ID: 8381314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
    Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
    Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
    Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
    Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.
    Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW
    Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
    Leander P; Golman K; Klaveness J; Holtz E; Olsson M; Leunbach I
    Invest Radiol; 1990 Oct; 25(10):1130-4. PubMed ID: 2127772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
    Young SW; Simpson BB; Ratner AV; Matkin C; Carter EA
    Magn Reson Med; 1989 Apr; 10(1):1-13. PubMed ID: 2502699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
    Youk JH; Lee JM; Kim CS
    AJR Am J Roentgenol; 2004 Oct; 183(4):1049-54. PubMed ID: 15385303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.